Form 4: West Pharmaceutical Services Executive Sells Shares
Insider Transaction (Form 4)
Annette F Favorite, Sr. VP & Chief HR Officer of West Pharmaceutical Services Inc, sold 8,135 shares of common stock on September 8, 2026 for $340.81 per share.
Summary
- Option exercise/conversion: acquired 2,817 Common Stock at $83.47 ($235,135) on September 8, 2026; holds 19,662 after (Direct).
- Open-market sale: disposed of 2,817 Common Stock at $340.81 ($960,062) on September 8, 2026; holds 16,845 after (Direct).
- Option exercise/conversion: acquired 2,818 Common Stock at $83.47 ($235,218) on September 8, 2026; holds 19,663 after (Direct).
- Open-market sale: disposed of 2,818 Common Stock at $340.81 ($960,403) on September 8, 2026; holds 16,845 after (Direct).
- Option exercise/conversion: acquired 2,500 Common Stock at $89.64 ($224,100) on September 8, 2026; holds 19,345 after (Direct).
- Open-market sale: disposed of 2,500 Common Stock at $340.81 ($852,025) on September 8, 2026; holds 16,845 after (Direct).
- Option exercise/conversion: disposed of 2,817 Stock Options (Right to Buy) on September 8, 2026; holds 2,818 after (Direct).
- Option exercise/conversion: disposed of 2,818 Stock Options (Right to Buy) on September 8, 2026 (Direct).
- Option exercise/conversion: disposed of 2,500 Stock Option (Right to Buy) on September 8, 2026; holds 7,524 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,772,489 of stock on the open market.
Insider Transactions
Annette F Favorite — Officer (Sr. VP & Chief HR Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Option exercise/conversion | Common Stock | 2,817 | $83 | $235.1K | 19,661.555 |
| 2026-09-08 | Open-market sale | Common Stock | 2,817 | $341 | $960.1K | 16,844.555 |
| 2026-09-08 | Option exercise/conversion | Common Stock | 2,818 | $83 | $235.2K | 19,662.555 |
| 2026-09-08 | Open-market sale | Common Stock | 2,818 | $341 | $960.4K | 16,844.555 |
| 2026-09-08 | Option exercise/conversion | Common Stock | 2,500 | $90 | $224.1K | 19,344.555 |
| 2026-09-08 | Open-market sale | Common Stock | 2,500 | $341 | $852.0K | 16,844.555 |
| 2026-09-08 | Option exercise/conversion | Stock Options (Right to Buy) | 2,817 | — | — | 2,818 |
| 2026-09-08 | Option exercise/conversion | Stock Options (Right to Buy) | 2,818 | — | — | 0 |
| 2026-09-08 | Option exercise/conversion | Stock Option (Right to Buy) | 2,500 | — | — | 7,524 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Option exercise/conversion (2,817 shares) |
| 2026-09-08 | Open-market sale (2,817 shares) |
| 2026-09-08 | Option exercise/conversion (2,818 shares) |
| 2026-09-08 | Open-market sale (2,818 shares) |
| 2026-09-08 | Option exercise/conversion (2,500 shares) |
| 2026-09-08 | Open-market sale (2,500 shares) |
| 2026-09-08 | Option exercise/conversion (2,817 shares) |
| 2026-09-08 | Option exercise/conversion (2,818 shares) |
| 2026-09-08 | Option exercise/conversion (2,500 shares) |
Keywords
insider transaction, Form 4, WST, WEST PHARMACEUTICAL SERVICES INC, bearish, Annette F Favorite
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.